Correction: Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response (Proceedings of the National Academy of Sciences of the United States of America (2018) 115 (E2960-E2969) DOI: 10.1073/pnas.1720696115);Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 13, 2018, Pages E2960-E2969

  Gao, Xinghua ^a   Cao, Qiuhua ^a   Cheng, Yan ^a   Zhao, Dandan ^a   Wang, Zhuo ^a,b   Yang, Hongbao ^a   Wu, Qijin ^a   You, Linjun ^a   Wang, Yue ^a   Lin, Yanting ^a   Li, Xianjing ^a   Wang, Yun ^a   Bian, Jin Song ^c   Sun, Dongdong ^b   Kong, Lingyi ^a   Birnbaumer, Lutz ^d,e   Yang, Yong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

Author keywords

Chronic stress; DSS induced colitis; Gut microbiota; Immune reaction; Mucin 2

Indexed keywords

INTERLEUKIN 6; LYSOZYME; MUCIN 2; STAT3 PROTEIN; DEXTRAN SULFATE; INTERLEUKIN-6, MOUSE; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BODY WEIGHT; CHRONIC STRESS; CONTROLLED STUDY; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME INHIBITION; INTESTINE FLORA; LAMINA PROPRIA; LIMIT OF QUANTITATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; COLITIS; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCIN-2; MURAMIDASE; STAT3 TRANSCRIPTION FACTOR; STRESS, PHYSIOLOGICAL;

EID: 85044539533     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1806622115     Document Type: Erratum

References (62)

1. Chi KR (2016) Epidemiology: Rising in the East. Nature 540:S100-S102.
2. Le CP, et al. (2016) Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun 7:10634.
3. Mawdsley JE, Rampton DS (2005) Psychological stress in IBD: New insights into pathogenic and therapeutic implications. Gut 54:1481-1491.
4. Engel GL (1969) Psychological factors in ulcerative colitis inman and gibbon. Gastroenterology 57:362-365.
5. Cornick S, Tawiah A, Chadee K (2015) Roles and regulation of the mucus barrier in the gut. Tissue Barriers 3:e982426.
6. Zhang YZ, Li YY (2014) Inflammatory bowel disease: Pathogenesis. World J Gastroenterol 20:91-99.
7. Ilott NE, et al. (2016) Defining the microbial transcriptional response to colitis through integrated host and microbiome profiling. ISME J 10:2389-2404.
8. Forbes JD, Van Domselaar G, Bernstein CN (2016) The gut microbiota in immunemediated inflammatory diseases. Front Microbiol 7:1081.
9. Berg RD (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4: 430-435.
10. Desai MS, et al. (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167:1339-1353.e21.
11. Martínez I, et al. (2013) Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 7:269-280.
12. Chassaing B, et al. (2015) Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519:92-96.
13. Tschurtschenthaler M, et al. (2014) Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration. Gut 63: 1921-1931.
14. Vlantis K, et al. (2016) TLR-independent anti-inflammatory function of intestinal epithelial TRAF6 signalling prevents DSS-induced colitis in mice. Gut 65:935-943.
15. Man SM, et al. (2015) Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer. Cell 162:45-58.
16. de Vrieze J (2013) Medical research. The promise of poop. Science 341:954-957.
17. Pigneur B, Sokol H (2016) Fecal microbiota transplantation in inflammatory bowel disease: The quest for the holy grail. Mucosal Immunol 9:1360-1365.
18. Vétizou M, et al. (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350:1079-1084.
19. Kim Y, Nam HG, Valenzano DR (2016) The short-lived African turquoise killifish: An emerging experimental model for ageing. Dis Model Mech 9:115-129.
20. O'Mahony SM, Clarke G, Dinan TG, Cryan JF (2017) Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle? Neuroscience 342: 37-54.
21. Moloney RD, et al. (2016) Stress and the microbiota-gut-brain axis in visceral pain: Relevance to irritable bowel syndrome. CNS Neurosci Ther 22:102-117.
22. Thaker PH, et al. (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12:939-944.
23. Grivennikov S, et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15:103-113.
24. Mitsuyama K, et al. (2007) Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease. Anticancer Res 27:3749-3756.
25. Ito H, et al. (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126:989-996.
26. Ito H (2005) Treatment of Crohn's disease with anti-IL-6 receptor antibody. J Gastroenterol 40:32-34.
27. Chu H, et al. (2016) Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352:1116-1120.
28. Meisel M, et al. (2017) Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis. ISME J 11:15-30.
29. Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167:915-932.
30. Johansson ME, et al. (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105:15064-15069.
31. Ijssennagger N, et al. (2015) Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci USA 112:10038-10043.
32. Van Kruiningen HJ, Colombel JF (2008) The forgotten role of lymphangitis in Crohn's disease. Gut 57:1-4.
33. Chen Y, et al. (2017) The pro-inflammatory cytokine TNF-α inhibits lymphatic pumping via activation of the NF-κB-iNOS signaling pathway. Microcirculation 24:e12364.
34. von der Weid PY, Rehal S, Ferraz JG (2011) Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr Opin Gastroenterol 27:335-341.
35. Hodge DR, Hurt EM, Farrar WL (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41:2502-2512.
36. Sommer J, et al. (2014) Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis. Int J Mol Med 34:651-660.
37. Dann SM, et al. (2008) IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol 180:6816-6826.
38. Begue B, et al. (2011) Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol 106:1544-1555.
39. Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356: 513-519.
40. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
41. Cekanaviciute E, et al. (2017) Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA 114: 10713-10718.
42. Yu Q, et al. (2015) Enterohepatic Helicobacter species as a potential causative factor in inflammatory bowel disease: A meta-analysis. Medicine (Baltimore) 94:e1773.
43. Tsoi H, et al. (2017) Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152:1419-1433.e5.
44. Al-Jashamy K, Murad A, Zeehaida M, Rohaini M, Hasnan J (2010) Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev 11:1765-1768.
45. Zhou Y, et al. (2016) Increased Enterococcus faecalis infection is associated with clinically active Crohn disease. Medicine (Baltimore) 95:e5019.
46. Surana NK, Kasper DL (2017) Moving beyond microbiome-wide associations to causal microbe identification. Nature 552:244-247.
47. Ho S, Pothoulakis C, Koon HW (2013) Antimicrobial peptides and colitis. Curr Pharm Des 19:40-47.
48. Salzman NH, et al. (2010) Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11:76-83.
49. Van der Sluis M, et al. (2006) Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131:117-129.
50. Hartmann P, et al. (2013) Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology 58:108-119.
51. Wenzel UA, et al. (2014) Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis. PLoS One 9:e100217.
52. Hasnain SZ, et al. (2013) IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. Gastroenterology 144:357-368.e9.
53. Yang K, et al. (2008) Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: Potential role of chronic inflammation. Cancer Res 68:7313-7322.
54. Bergstrom KS, et al. (2010) Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 6:e1000902.
55. Cobo ER, Kissoon-Singh V, Moreau F, Chadee K (2015) Colonic MUC2 mucin regulates the expression and antimicrobial activity of β-defensin 2. Mucosal Immunol 8: 1360-1372.
56. Cobo ER, Kissoon-Singh V, Moreau F, Holani R, Chadee K (2017) MUC2 mucin and butyrate contribute to the synthesis of the antimicrobial peptide cathelicidin in response to Entamoeba histolytica- and dextran sodium sulfate-induced colitis. Infect Immun 85:e00905-16.
57. Lee M, et al. (2009) Hen egg lysozyme attenuates inflammation and modulates local gene expression in a porcine model of dextran sodium sulfate (DSS)-induced colitis. J Agric Food Chem 57:2233-2240.
58. Hernández-Chirlaque C, et al. (2016) Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis. J Crohn's Colitis 10:1324-1335.
59. Kitajima S, Morimoto M, Sagara E, Shimizu C, Ikeda Y (2001) Dextran sodium sulfateinduced colitis in germ-free IQI/Jic mice. Exp Anim 50:387-395.
60. National Research Council (2011) Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC), 8th Ed.
61. Lamkin DM, et al. (2012) Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling. Brain Behav Immun 26:635-641.
62. Zigmond E, et al. (2012) Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37: 1076-1090.